Sperry BW, Vamenta MS, Gunta SP, et al. Influence of body Mass Index on Radiation Exposure across Imaging Modalities in the evaluation of chest Pain. J Am Heart Assoc. 2024;13:e033566.
Article PubMed PubMed Central CAS Google Scholar
Driessen RS, Raijmakers PG, Stuijfzand WJ, Knaapen P. Myocardial perfusion imaging with PET. Int J Cardiovasc Imaging. 2017;33:1021–31.
Article PubMed PubMed Central Google Scholar
Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the evaluation and diagnosis of chest Pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol. 2021;78:e187–285.
Winchester DE, Maron DJ, Blankstein R, ACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR, et al. STS 2023 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Chronic Coronary Disease. J Am Coll Cardiol. 2023;81:2445–67.
Ommen SR, Ho CY, Asif IM, et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the management of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2024;83:2324–405.
Nagueh SF, Phelan D, Abraham T, et al. Recommendations for Multimodality Cardiovascular Imaging of Patients with hypertrophic cardiomyopathy: an update from the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2022;35:533–69.
Yetman AT, McCrindle BW, MacDonald C, Freedom RM, Gow R. Myocardial bridging in children with hypertrophic cardiomyopathy–a risk factor for sudden death. N Engl J Med. 1998;339:1201–9.
Article PubMed CAS Google Scholar
Huang G, Fadl SA, Sukhotski S, Matesan M. Apical variant hypertrophic cardiomyopathy multimodality imaging evaluation. Int J Cardiovasc Imaging. 2020;36:553–61.
von Lama C, Sanghani R. PET myocardial perfusion imaging in the diagnosis of apical hypertrophic cardiomyopathy. J Nucl Cardiol. 2022;29:1452–6.
Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base and standardized methods of imaging. J Nuclear Cardiol. 2019;26:2065–123.
Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 2 of 2—Diagnostic criteria and appropriate utilization. J Nuclear Cardiol. 2020;27:659–73.
Dorbala S, Vangala D, Bruyere J Jr, et al. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail. 2014;2:358–67.
Article PubMed PubMed Central Google Scholar
Chacko L, Kotecha T, Ioannou A, et al. Myocardial perfusion in cardiac amyloidosis. Eur J Heart Fail. 2024;26:598–609.
Article PubMed CAS Google Scholar
Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131:624–32.
Lehtonen J, Uusitalo V, Pöyhönen P, Mäyränpää MI, Kupari M. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur Heart J. 2023;44:1495–510.
Article PubMed PubMed Central Google Scholar
Cheng RK, Kittleson MM, Beavers CJ, et al. Diagnosis and management of Cardiac Sarcoidosis: A Scientific Statement from the American Heart Association. Circulation. 2024;149:e1197–216.
Chazal HMd, Buono MGD, Keyser-Marcus L, et al. Stress cardiomyopathy diagnosis and treatment. J Am Coll Cardiol. 2018;72:1955–71.
Anderson JL, Horne BD, Le VT, et al. Spectrum of radionuclide perfusion study abnormalities in takotsubo cardiomyopathy. J Nucl Cardiol. 2022;29:1034–46.
Heymans S, Lakdawala NK, Tschöpe C, Klingel K. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches. Lancet. 2023;402:998–1011.
留言 (0)